Intracranial stenting after an initial ischemic stroke may decrease risk of recurrent stroke more than use of aspirin or warfarin
Intracranial stenting after an initial ischemic stroke
may decrease risk of recurrent stroke more than use of aspirin or warfarin, according
to a presentation at International Stroke Conference 2007.
Previous studies showed that despite anticoagulation
treatment, patients with symptomatic intracranial atherosclerotic stenosis had
an 11 percent increased risk of ischemic stroke in the area near the blockage
after one year and a 14 percent increased risk after two years.
In the current study, Chinese researchers investigated
long-term outcomes of intracranial stenting and explored factors associated with
subsequent stroke. Intracranial stenting is a minimally invasive procedure that
inserts a stent pre-mounted on a balloon. After the stent is placed, the balloon
is removed without having been expanded.
“Commonly, the stenosis is 50 percent or more,” said
Wei-Jian Jiang, MD, lead author of the study at Beijing Tiantan Hospital in China.
“Intracranial atherosclerosis is an important cause of ischemic stroke that is
more common among Asians, Hispanics and blacks.”
Researchers reviewed medical data on 213 people (176
men, 37 women; average age, 53 years) who had stroke or transient ischemic attack
resulting from intracranial stenosis and underwent stenting in a brain artery
to improve blood flow to affected regions of the brain.
Within 30 days of stenting, 10 of 213 had strokes - the
primary endpoint. Seven had ischemic strokes and three had hemorrhagic strokes.
Another nine patients had a secondary endpoint event: seven had emergent cerebral
revascularization and two had asymptomatic intracranial hemorrhage.
Researchers followed 198 patients who did not have a
stroke within the first 30 days. During a median follow-up of about two years,
seven had ischemic stroke in the area of the stenting, whereas three had ischemic
stroke in a different area.
This study shows that ischemic stroke risk in the area
of stenting (including stroke within 30 days) was just 6.9 percent after one year
and 8.9 percent after two years.
“Our study shows a better long-term outcome of patients
with symptomatic atherosclerotic stenosis after elective stenting,” Jiang said.
However, he said blockages that were difficult to access
and diabetes increased the risk of subsequent stroke in the area around the stent.
Intracranial stenting is still an investigational procedure.
Some high-risk patients - those not helped by medical therapy, those who have
severe stenosis (greater than 70 percent blockage), and patients who have brain
imaging that shows a lack of blood flow through an area of the brain can be referred
to an interventional neuroradiologist.
The referrals should be to a doctor highly experienced
with the procedure, “because intracranial stenting itself may lead to a stroke,
even death, and a high rate of procedural complication can offset the potential
benefits,” Jiang said.
|